Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
Johnson & Johnson reports 2Q earnings beat and raises guidance
07:41am, Thursday, 20'th Jul 2023
Johnson & Johnson (NYSE:JNJ) has delivered second-quarter earnings that beat expectations and has raised its full-year guidance, sending its shares higher in Thursday pre-marketing trading. The comp
Kenvue earnings top estimates in J&J spinoff's first quarterly report since IPO
07:32am, Thursday, 20'th Jul 2023
J&J still owns a 90% stake in Kenvue, meaning it can generally control the direction of the consumer health spinoff's business for the time being.
5 Things to Know Before Markets Open
07:30am, Thursday, 20'th Jul 2023
Tesla shares fell after reporting revenue that beat expectations but lower profit margins thanks to price cuts, and Netflix shares tumbled after it missed on revenue projections despite strong subscri
Johnson & Johnson's stock up 2.4% premarket after earnings top estimates and company raises guidance
06:34am, Thursday, 20'th Jul 2023
Johnson & Johnson's stock JNJ, -0.20% rose 2.4% in premarket trade Thursday, after the health care company posted better-than-expected second-quarter earnings and raised its guidance. The company post
Johnson & Johnson beats on earnings, hikes full-year guidance as medtech sales surge
06:24am, Thursday, 20'th Jul 2023
The results come amid investor anxiety over the thousands of lawsuits claiming that J&J's talc-based baby powder and other products caused cancer.
J&J raises annual profit forecast on medical devices, cancer drugs strength
06:22am, Thursday, 20'th Jul 2023
Johnson & Johnson raised its 2023 profit forecast on Thursday, banking on the strength in its medical devices business and demand for its cancer drugs such as Darzalex.
Our Dividend Growth Portfolio Continues To Outpace The S&P 500
10:56pm, Wednesday, 19'th Jul 2023
In 2015, I purchased 15 of the largest cap U.S. dividend achievers, which have continued to outpace the S&P 500. The portfolio was designed to provide greater protection during recessions and severe b
Johnson & Johnson must pay $18.8m to cancer patient in baby powder lawsuit
01:58pm, Wednesday, 19'th Jul 2023
Jury rules in favor of California man who says he developed a deadly cancer from heavy exposure to talc powder since childhood
Johnson & Johnson must pay $18.8 million to California cancer patient in baby powder suit
10:31pm, Tuesday, 18'th Jul 2023
Johnson & Johnson must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle t
J&J must pay $18.8 mln to California cancer patient in baby powder suit
07:21pm, Tuesday, 18'th Jul 2023
Johnson & Johnson's must pay $18.8 million to a California man who said he developed cancer from exposure to its baby powder, a jury decided on Tuesday, a setback for the company as it seeks to settle
Johnson & Johnson joins Merck, others, in fighting Medicare drug-price program
04:40pm, Tuesday, 18'th Jul 2023
Johnson & Johnson JNJ, -0.01% has joined companies such as Merck & Co. Inc. MRK, +0.36%, Bristol Myers Squibb Co. BMY, +0.24% and other entities in suing the federal government over Medicare's drug-pr
Johnson & Johnson sues Biden administration to stop Medicare from negotiating its own drug prices
03:43pm, Tuesday, 18'th Jul 2023
Johnson & Johnson (NYSE:JNJ) is suing the US government in a bid to block a program that would give the government health insurance program Medicare the ability to negotiate for lower drug prices. J
J&J (JNJ) to Begin Q2 Earnings Season for Drug, Biotech Sector
01:35pm, Tuesday, 18'th Jul 2023
Growth in J&J's (JNJ) Pharma unit is expected to have been driven by drugs like Darzalex. In the MedTech segment, recovery in surgical procedures and new product launches are likely to have pushed sal
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
01:07pm, Tuesday, 18'th Jul 2023
Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.
J&J sues US govt to halt Medicare drug price negotiation plans
11:59am, Tuesday, 18'th Jul 2023
Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block enforcement of a program that gives Medicare the power to negotiate drug prices.
